enVVeno Medical (NVNO) Shares Outstanding (Weighted Average) (2017 - 2026)

enVVeno Medical's Shares Outstanding (Weighted Average) history runs 10 years deep, the most recent figure standing at $654000.0 for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 12.56% year-over-year to $654000.0; the TTM figure through Mar 2026 stood at $654000.0 (up 12.56% YoY), while the FY2025 annual figure was $589000.0, up 20.2% from the prior year.
• Shares Outstanding (Weighted Average) was $654000.0 for Q1 2026 at enVVeno Medical, up from $589000.0 in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $20.4 million in Q2 2025 to a low of $490000.0 in Q4 2024.
• Historically, Shares Outstanding (Weighted Average) has averaged $10.7 million across 5 years, with a median of $11.2 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Weighted Average) soared 156729.61% in 2022, then tumbled 96.38% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $11.2 million in 2022, then climbed by 9.54% to $12.3 million in 2023, then slumped by 96.02% to $490000.0 in 2024, then rose by 20.2% to $589000.0 in 2025, then gained by 11.04% to $654000.0 in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $654000.0 (Q1 2026), $589000.0 (Q4 2025), and $20.2 million (Q3 2025), per Business Quant data.